The London Joint Working Group on Substance Use and Hepatitis C
LJWG was formed in 2009 to help drive improvements in the prevention, diagnosis and treatment of hepatitis C in people who use drugs in London.
We work together to improve outcomes for people with hepatitis C in this vulnerable population. The LJWG collaborates with stakeholders from the health service, providers, policy makers, pharmaceutical companies and service users.
THE LJWG 2023 ANNUAL CONFERENCE
We would like to say thank you to all of the speakers, guests and partner organisations who contributed to our conference on June 9th. It was vital to hear so many perspectives from those working in hepatitis C care, with lived experience, or both. You can watch videos of all four sessions of the conference on our YouTube channel or view the slides from the presentations here.
Watch our journey here:
What we do
Projects
We run pilot projects to improve hepatitis C diagnosis, care and treatment across London.
Reports
We produce reports to help people understand the wider challenges
and overcome barriers to addressing hepatitis C.
Resources
We create well-researched and tested resources for substance misuse services and people at risk of hepatitis C.
News and Events
LJWG shortlisted for C+D awards for innovative hepatitis C pharmacy testing pilot
Latest News & Resources

New Partnership Launched
Setting the direction for London to become the first global city to eliminate hepatitis C

The Opportunity
In March 2020 the LJWG and partners launched the ‘Routemap to eliminating hepatitis C in London’

Peer-based needle exchange
A new report exploring the case for an innovative peer-based needle and syringe exchange service in the capital.